Investing carries serious risks, including partial or total loss of capital. Please read the Information Note and the Risk factors and login before investing.

Neutraceutical food patent company

Equity Belgium 73 investors Tax Shelter applicable

Tax Shelter

Making industrial food cholesterol-friendly
Information Note Terms & Conditions
€1,000,000
Pre money valuation
33.3%
Equity offered
€94,100
Amount raised
€50,000
Committed by co-investors
64 days
Remaining
€50,000
Minimum target
188% funded

BUSINESS PLAN

The fundraising will help develop the marketing of the invention based on the creation of partnerships with the food industry. The income will come from selling the patented substance (invention) to the food industry. The company plans to sell the raw material to four main sectors. The forecasted sales have been defined as followed:

2020: Ingredient will be sold to the dairy industry (pre-agreement registered with a Belgian dairy company)

2021: Ingredient will be sold to fatty food producers (hamburgers/pizza) + cumulative sales on the Dairy industry

2022 : Ingredient will be sold to sauce producers + cumulative sales on the dairy industry & fatty food industry

2023 : Ingredient will be sold to ice cream companies + cumulative sales on the dairy industry & fatty food & sauce industries

The gross margin percentage amounted to 40%. The payroll costs are related to the management fees of the team. The services and other costs are mainly composed of development's costs (extented study), marketing, fixed costs such accountancy fees, building rental, ... The company will be break-even in 2021


A full financial plan with arguments is available on request.

TAX SHELTER 45%

This business qualifies for the startup tax shelter. If you meet the conditions, 45% of your investment will be reducted from your personal income taxes. Read more…

Raise summary

Crowd investments €94,100
Committed by co-investors €50,000
Amount raised €144,100
Min. total fundraising €150,000
Max. total fundraising €500,000
Pre-money valuation €1,000,000
Post-money valuation min. €1,150,000
Post-money valuation max. €1,500,000